Request Trial
shutterstock_1585472158_alexsey_t17
Alexsey t17 / Shutterstock.com
12 January 2023PharmaLiz Hockley

Drugs to Watch report: 15 blockbusters for 2023

Clarivate study highlights treatments with blockbuster potential | IV, Parkinson’s disease, Crohn’s disease, alopecia, multiple myeloma and breast cancer make the list | Nine blockbusters from China also predicted.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Pharma
Pharmascience v Janssen: Canada court updates methods of medical treatment protection
23 July 2026   Canada has firmly slammed the door on patenting methods of medical treatment—but the battle over what counts as a "medical method" is only just beginning. Scott MacKendrick of ROBIC examines a landmark decision that leaves the door ajar for future litigation over complex drug-dosing regimens.
Pharma
Exelixis opens two-front patent dispute over Cabometyx copies
9 July 2026   Separate lawsuits target Indian and Taiwanese pharma companies as Exelixis seeks to keep rival cabozantinib products off the US market until key patents expire.
Pharma
Influential Women in IP 2026: Who made the list?
7 July 2026   Leading women from the pharmaceutical and biotechnology sectors are among the more than 100 professionals recognised in a newly released Influential Women in IP 2026 list, which celebrates leadership, expertise and innovation.


Editor's picks

Buying the brains: Why is Big Pharma shopping for innovation?
Regulation & Industry
Buying the brains: Why is Big Pharma shopping for innovation?
27 July 2026

Editor's picks

Regulation & Industry
Buying the brains: Why is Big Pharma shopping for innovation?
27 July 2026
Biotech
Sanofi launches mRNA vaccine lawsuits at Moderna and Pfizer
15 July 2026
Pharma
What’s at stake in Australia’s biggest pharma patent appeal in years?
1 July 2026
Biotech
Pfizer’s US Paxlovid patent fight turns on a single error
25 June 2026
Regulation & Industry
Novartis and Eli Lilly sign separate $1.9bn novel drug deals
25 June 2026
Regulation & Industry
Insilico lands potential $2.5bn AI biotech partnership
22 June 2026

More features

Fish & Richardson adds AI and medical device specialist
Where Big Pharma is betting big in the M&A boom
Boston Scientific overturns $42m patent verdict on appeal
Buying the brains: Why is Big Pharma shopping for innovation?
FisherBroyles and Hong Kong affiliate draft in senior partners
‘Engagement and collaboration’: New IP Federation president builds on strong foundations
AbbVie, Allergan takes on Swiss aesthetics rival over syringe design
Trump slaps 100% tariff on generic drugs in US manufacturing push